All results
5 results for tests
-
AEVI-007
The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease. ### Inclusion Criteria: 1.…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
DREAM
The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
Takeda TAK-999-3001
The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
First-In-Human Study of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
This study is an international, multi-center, study of Pompe disease patients that are currently receiving enzyme-replacement therapy (ERT). The purpose of…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal…
- Ages
- 18 Years - 75 Years
- Sexes
- All